Mary C. MacLean, RPAC

Mary MacLean practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Mary MacLean's NPI, 1356378012, was assigned on June 27, 2006. Mary MacLean holds New York license 008494.

Mary MacLean's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Mary MacLean's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Mary MacLean to 1 more group practice or clinic and 1 medical group, each named with a free account. Mary MacLean's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Mary MacLean practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Mary MacLean's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Mary MacLean is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Mary MacLean is licensed in New York.

Dmand AI lists acute sinusitis, acute skin infection, asthma, chronic kidney disease, conjunctivitis, contact dermatitis, corns and calluses and ear eustachian tube disorders among the conditions Mary MacLean treats.

CMS data shows 222 Medicare services from Mary MacLean across 4 procedure codes in 2024, for 110 Medicare patients. Medicare paid $8,742 for them. Every service was in an office.

CMS counts 110 Medicare patients who saw Mary MacLean in 2024. The largest group is 65 to 74, with 44 patients. 72% of them have high blood pressure, and 67% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mary MacLean's median patient age at 66, with 64% women.

In 2024, Mary MacLean wrote 3,058 Medicare Part D claims for 807 patients. 89% of them were for generic drugs. CMS names the drug for 2,575 of them, across 69 drugs with 11 or more claims each, at $145,969 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Mary MacLean for performance year 2024, reported as part of a group. Mary MacLean accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mary MacLean as offering telehealth.